These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

250 related items for PubMed ID: 10827541

  • 1. [Meniere's disease. The clinical effect of gentamicin treatment].
    Kjaer D, Pedersen CB.
    Ugeskr Laeger; 2000 May 08; 162(19):2739-43. PubMed ID: 10827541
    [Abstract] [Full Text] [Related]

  • 2. Long-term hearing outcome in patients receiving intratympanic gentamicin for Ménière's disease.
    Wu IC, Minor LB.
    Laryngoscope; 2003 May 08; 113(5):815-20. PubMed ID: 12792316
    [Abstract] [Full Text] [Related]

  • 3. Intratympanic gentamicin for intractable Meniere's disease.
    Perez N, Martín E, García-Tapia R.
    Laryngoscope; 2003 Mar 08; 113(3):456-64. PubMed ID: 12616197
    [Abstract] [Full Text] [Related]

  • 4. [Intratympanic gentamicin treatment for intractable Menière's disease].
    Gilony D, Wolf M, Kronenberg J.
    Harefuah; 2004 Jan 08; 143(1):4-7, 88. PubMed ID: 14748278
    [Abstract] [Full Text] [Related]

  • 5. Continuous intratympanic infusion of gentamicin via a microcatheter in Menière's disease.
    Schoendorf J, Neugebauer P, Michel O.
    Otolaryngol Head Neck Surg; 2001 Feb 08; 124(2):203-7. PubMed ID: 11226958
    [Abstract] [Full Text] [Related]

  • 6. Intentional ablation of vestibular function using commercially available topical gentamicin-betamethasone eardrops in patients with Meniere's disease: further evidence for topical eardrop ototoxicity.
    Kaplan DM, Hehar SS, Bance ML, Rutka JA.
    Laryngoscope; 2002 Apr 08; 112(4):689-95. PubMed ID: 12150525
    [Abstract] [Full Text] [Related]

  • 7. Transtympanic gentamicin and fibrin tissue adhesive for treatment of unilateral Menière's disease: effects on vestibular function.
    Casani A, Nuti D, Franceschini SS, Gaudini E, Dallan I.
    Otolaryngol Head Neck Surg; 2005 Dec 08; 133(6):929-35. PubMed ID: 16360516
    [Abstract] [Full Text] [Related]

  • 8. Low-dose intratympanic gentamicin treatment for dizziness in Ménière's disease.
    Longridge NS, Mallinson AI.
    J Otolaryngol; 2000 Feb 08; 29(1):35-9. PubMed ID: 10709170
    [Abstract] [Full Text] [Related]

  • 9. Long-term results after interval therapy with intratympanic gentamicin for Menière's disease.
    Lange G, Maurer J, Mann W.
    Laryngoscope; 2004 Jan 08; 114(1):102-5. PubMed ID: 14710003
    [Abstract] [Full Text] [Related]

  • 10. Middle ear exploration in patients with Ménière's disease who have failed outpatient intratympanic gentamicin therapy.
    Crane BT, Minor LB, Della Santina CC, Carey JP.
    Otol Neurotol; 2009 Aug 08; 30(5):619-24. PubMed ID: 19503016
    [Abstract] [Full Text] [Related]

  • 11. Benign paroxysmal positional vertigo in patients with Ménière's disease treated with intratympanic gentamycin.
    Perez N, Martin E, Zubieta JL, Romero MD, Garcia-Tapia R.
    Laryngoscope; 2002 Jun 08; 112(6):1104-9. PubMed ID: 12160282
    [Abstract] [Full Text] [Related]

  • 12. Intratympanic gentamicin injection for the treatment of Meniere's disease.
    Youssef TF, Poe DS.
    Am J Otol; 1998 Jul 08; 19(4):435-42. PubMed ID: 9661751
    [Abstract] [Full Text] [Related]

  • 13. Treatment of Ménière's disease by low-dosage intratympanic gentamicin application: effect on otolith function.
    Helling K, Schönfeld U, Clarke AH.
    Laryngoscope; 2007 Dec 08; 117(12):2244-50. PubMed ID: 17909448
    [Abstract] [Full Text] [Related]

  • 14. Hearing results following intratympanic gentamicin perfusion for Ménière's disease.
    Kyrodimos E, Aidonis I, Sismanis A.
    J Laryngol Otol; 2009 Apr 08; 123(4):379-82. PubMed ID: 18954493
    [Abstract] [Full Text] [Related]

  • 15. Treatment of Menière's disease with topical gentamicin: a preliminary report.
    Nedzelski JM, Bryce GE, Pfleiderer AG.
    J Otolaryngol; 1992 Apr 08; 21(2):95-101. PubMed ID: 1583716
    [Abstract] [Full Text] [Related]

  • 16. Auditory results after vestibular nerve section and intratympanic gentamicin for Ménière's disease.
    Colletti V, Carner M, Colletti L.
    Otol Neurotol; 2007 Feb 08; 28(2):145-51. PubMed ID: 17255880
    [Abstract] [Full Text] [Related]

  • 17. Long-term disability of class A patients with Ménière's disease after treatment with intratympanic gentamicin.
    Boleas-Aguirre MS, Sánchez-Ferrandiz N, Guillén-Grima F, Perez N.
    Laryngoscope; 2007 Aug 08; 117(8):1474-81. PubMed ID: 17607149
    [Abstract] [Full Text] [Related]

  • 18. Long-term results of gentamicin inner ear perfusion in Ménière's disease.
    Suryanarayanan R, Cook JA.
    J Laryngol Otol; 2004 Jul 08; 118(7):489-95. PubMed ID: 15318953
    [Abstract] [Full Text] [Related]

  • 19. Low dose transtympanic gentamicin treatment for intractable Meniere's disease: a prospective study.
    Kasemsuwan L, Jariengprasert C, Ruencharopen S, Orathai P.
    J Med Assoc Thai; 2007 Feb 08; 90(2):327-34. PubMed ID: 17375639
    [Abstract] [Full Text] [Related]

  • 20. Long-term results of low dose intramuscular streptomycin for Menière's disease.
    Shea JJ, Ge X, Orchik DJ.
    Am J Otol; 1994 Jul 08; 15(4):540-4. PubMed ID: 8588611
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.